Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Honda Motor Company Ltd. Common Stock (HMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Honda Motor Company Ltd. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Honda Motor Company Ltd. Common Stock trades at $32.7 (market cap $42.17B). The key difference: Honda Motor Company Ltd. Common Stock is far larger — about 3.4× Halozyme Therapeutics Inc. Common Stock's market cap, and Honda Motor Company Ltd. Common Stock pays a 4.1% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Honda Motor Company Ltd. Common Stock for 1 Days on average.
| HALO | HMC | |
|---|---|---|
Market Cap | $12.58B | $42.17B |
Volume | 2,179,278 | 1,251,308 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $33.37 |
52-Week Low | $61.63 | $23.49 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $39.34B |
Dividend Yield | — | 4.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Honda Motor Company Ltd. Common Stock
Honda Motor manufactures automobiles, motorcycles, power products, and related financial services. Its brands serve consumer and commercial transportation markets globally.
Read more on HMC →
